498 related articles for article (PubMed ID: 29156643)
1. Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.
Testa U; Castelli G; Pelosi E
Med Sci (Basel); 2017 Nov; 5(4):. PubMed ID: 29156643
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
3. Melanoma progression.
Elder DE
Pathology; 2016 Feb; 48(2):147-54. PubMed ID: 27020387
[TBL] [Abstract][Full Text] [Related]
4. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.
Ohashi A; Funasaka Y; Ueda M; Ichihashi M
Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066
[TBL] [Abstract][Full Text] [Related]
5. Human melanocytic neoplasms and their etiologic relationship with sunlight.
Elder DE
J Invest Dermatol; 1989 May; 92(5 Suppl):297S-303S. PubMed ID: 2654303
[TBL] [Abstract][Full Text] [Related]
6. Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report.
Mordoh A; Triviño Pardo JC; Carri I; Barrio MM; Mordoh J; Aris M
BMC Med Genomics; 2023 Jan; 16(1):1. PubMed ID: 36604730
[TBL] [Abstract][Full Text] [Related]
7. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic impact of nuclear DNA content and proliferative activity in benign and malignant melanocytic lesions.
Steinbeck ZR; Heselmeyer KM; Gerlach B; Björnhagen V; Auer GU
Melanoma Res; 1996 Feb; 6(1):37-43. PubMed ID: 8640068
[TBL] [Abstract][Full Text] [Related]
9. Intermediate-effect biomarkers in prevention of skin cancer.
Doré JF; Pedeux R; Boniol M; Chignol MC; Autier P
IARC Sci Publ; 2001; 154():81-91. PubMed ID: 11220671
[TBL] [Abstract][Full Text] [Related]
10. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
[TBL] [Abstract][Full Text] [Related]
11. PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas).
Medic S; Ziman M
PLoS One; 2010 Apr; 5(4):e9977. PubMed ID: 20421967
[TBL] [Abstract][Full Text] [Related]
12. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.
Melamed RD; Aydin IT; Rajan GS; Phelps R; Silvers DN; Emmett KJ; Brunner G; Rabadan R; Celebi JT
J Invest Dermatol; 2017 Apr; 137(4):905-909. PubMed ID: 27890785
[TBL] [Abstract][Full Text] [Related]
13. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
[TBL] [Abstract][Full Text] [Related]
14. Stem cell spreading dynamics intrinsically differentiate acral melanomas from nevi.
Eshiba S; Namiki T; Mohri Y; Aida T; Serizawa N; Shibata T; Morinaga H; Nanba D; Hiraoka Y; Tanaka K; Miura K; Tanaka M; Uhara H; Yokozeki H; Saida T; Nishimura EK
Cell Rep; 2021 Aug; 36(5):109492. PubMed ID: 34348144
[TBL] [Abstract][Full Text] [Related]
15. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
Tóth-Molnár E; Hammer H; Oláh J
Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
[TBL] [Abstract][Full Text] [Related]
17. UV-Induced Somatic Mutations Driving Clonal Evolution in Healthy Skin, Nevus, and Cutaneous Melanoma.
Loras A; Gil-Barrachina M; Marqués-Torrejón MÁ; Perez-Pastor G; Martinez-Cadenas C
Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143375
[TBL] [Abstract][Full Text] [Related]
18. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.
Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K
Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880
[TBL] [Abstract][Full Text] [Related]
19. Expression of soluble adenylyl cyclase in acral melanomas.
Li H; Kim SM; Savkovic V; Jin SA; Choi YD; Yun SJ
Clin Exp Dermatol; 2016 Jun; 41(4):425-9. PubMed ID: 26290224
[TBL] [Abstract][Full Text] [Related]
20. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
